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higher morbidity, and risks related with gener‑
al anesthesia.
The current literature data show mostly unan‑
imously that octogenarians and younger patients 
do not differ in terms of TLE outcomes5-7; how‑
ever, the issue remains controversial. Williams 
et al8 demonstrated that the overall rate of ad‑
verse events was higher in octogenarians. Fur‑
thermore, according to the prospective multi‑
center ELECTRa (European Lead Extraction Con‑
trolled) study on TLE procedures, the age above 
IntroductIon Transvenous lead extraction 
(TLE) is the cornerstone in the management 
of cardiovascular implantable electronic device 
(CIED)–related adverse events.1-3 Due to the pro‑
longed survival of patients with CIEDs, leads 
need to be frequently removed in elderly indi‑
viduals. Population aging and a growing rate of 
older persons with multiple chronic comorbid‑
ities pose new challenges for clinical practice.4 
Elderly patients, compared with younger ones, 
may have worse outcomes of TLE due to frailty, 
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AbstrAct
IntroductIon Due to the prolonged survival of patients with cardiovascular implantable electronic 
devices, leads often need to be removed in elderly individuals.
objEctIvEs We aimed to analyze indications for transvenous lead extraction (TLE), procedure effectiveness 
and safety, as well as 30 ‑day follow ‑up in younger patients (≤80 years) and octogenarians (>80 years).
PAtIEnts And mEthods This prospective study included 667 patients who underwent TLE: 90 octo‑
genarians (13.5%) at a mean age of 83.8 (range, 80.4–93) years and 577 younger patients (86.5%) at a 
mean age of 64.2 (range, 18.9–79.9) years.
rEsuLts Octogenarians had a greater number of comorbidities, fewer implantable cardioverter‑
‑defibrillators implanted, and more frequently had infection as an indication for TLE, as compared with 
younger patients (33.3% vs 17.1%; P <0.001). In octogenarians, 138 leads were extracted, as compared 
with 894 leads in younger patients. Octogenarians and younger patients had similar rates of complete 
lead removal (98.6% and 97.1%, respectively; P = 0.48), total procedural success (97.8% and 96%, 
respectively; P = 0.7), major complications (0% and 1.6%, respectively; P = 0.45), and minor compli‑
cations (2.2% and 1.6%, respectively; P = 0.45). There was 1 death associated with TLE in younger 
patients. Non–procedure ‑related deaths within 30 days after TLE were more frequent in octogenarians 
than in younger patients (5.6% vs 1.9%; P = 0.04).
concLusIons We showed that TLE in patients older than 80 years seems to be as effective as in younger 
patients; however, it is associated with significantly higher non–procedure ‑related 30 ‑day mortality.
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dementia, etc) were managed conservatively. On 
the other hand, in the case of an infectious indi‑
cation for TLE, such patients were routinely re‑
ferred to the regional court for a ruling.
Data were collected from records taken at the 
time of device implantation, records from follow‑
‑up visits at outpatient cardiology clinics, and 
medical information obtained during index ad‑
missions for TLE and 30 days after the procedure.
The study groups were compared with regard to 
demographic characteristics (age, sex), body mass 
index (BMI), New York Heart Association (NYHA) 
functional class, left ventricular ejection fraction 
(LVEF), comorbidities defined by the Charlson 
Comorbidity Index (CCI), laboratory tests (he‑
moglobin, creatinine, and estimated glomeru‑
lar filtration rate [eGFR]), type of the implanted 
CIED, number of CIED ‑related procedures before 
TLE (implantation, box change, device upgrade), 
and indications for TLE.
The CCI score was determined based on 19 dis‑
eases weighted according to their association 
with mortality.12 The Chronic Kidney Disease Ep‑
idemiology Collaboration equation was used to 
calculate eGFR. Indications for TLE were divided 
into 3 categories: lead ‑dependent infective endo‑
carditis (LDIE), isolated local infection (LI), and 
indications other than infection. The Modified 
Duke Leads Criteria were used to diagnose LDIE, 
whereas LI was diagnosed based on signs of lo‑
cal inflammation restricted to the device pock‑
et: erythema, warmth, pain, swelling, wound 
dehiscence, purulent discharge, skin erosion, or 
sinus formation. When both LDIE and LI were 
present, LDIE was considered the primary in‑
dication for TLE.
In addition, both groups were analyzed and 
compared for the following characteristics: per‑
centage of unipolar leads, percentage of passive 
fixation leads, percentage of nonfunctional or 
abandoned leads, age of extracted leads, age of 
the oldest extracted lead, total age of all extract‑
ed leads (a sum of extracted lead dwell times per 
procedure [years]), number of extracted leads dur‑
ing TLE, fluoroscopy time during TLE, techniques 
used during TLE, effectiveness of TLE, complete 
or incomplete lead removal for each lead removed, 
complications during the intraoperative and 30‑
‑day postoperative period.
The effectiveness of TLE was divided into 3 cat‑
egories (complete success, clinical success, and 
failure) according to the current consensus of 
the Heart Rhythm Society and the European 
Heart Rhythm Association (EHRA).1-3 We used 
the following definitions: 1) complete procedural 
success—removal of all targeted leads and all lead 
material from the vascular space, without any per‑
manently disabling complications or procedure‑
‑related death; 2) clinical success—removal of all 
targeted leads and lead material from the vascular 
space or retention of a small portion of the lead, 
which does not negatively impact the procedure 
outcome; it may be a tip or a small part of the lead 
(a conductor coil, insulation, or the combination 
68 years  is one of the predictors of increased 
all ‑cause mortality during hospitalization.9 Ad‑
ditionally, Kennergren et al10 reported that in 
a low number of patients with class II indications 
for TLE, leads were not extracted because of ad‑
vanced patient age. Brunner et al11 observed that 
patients over the age of 65 years experienced ma‑
jor adverse events and major cardiovascular in‑
jury, which was the first report stating that pa‑
tients older than 65 years had higher 30 ‑day mor‑
tality following TLE.
Conflicting evidence prompted us to conduct 
a prospective single ‑center study on the relation‑
ship between patients’ age and outcome of TLE, 
with a particular focus on the relation between 
30 ‑day mortality and risk factors.
PAtIEnts And mEthods We aimed to assess 
indications for TLE, procedure effectiveness 
and safety, as well as all ‑cause mortality within 
30 days after the procedure in patients younger 
and older than 80 years.
We performed a prospective analysis (a case‑
‑control study) of the records of all patients who 
underwent TLE from October 2011 to April 2019. 
The study protocol was approved by the Research 
and Ethics Committee of Jagiellonian University 
(KBET/259/B/2011). Written informed consent 
was obtained from all patients for the use of their 
anonymous data in this article. The study proto‑
col conformed with the 1975 Declaration of Hel‑
sinki and complied with the principles of Good 
Clinical Practice guidelines.
Patients with pacemakers or implantable 
cardioverter ‑defibrillator (ICD) leads implanted 
later than 1 year before TLE were excluded from 
the analysis.
The population was divided into 2 groups based 
on age at the time of the procedure: the group of 
younger patients included those at 80 years of 
age and younger, and the group of octogenari‑
ans, those over 80 years of age.
Transvenous lead extraction was performed 
only in patients expected to survive at  least 
12 months. Octogenarians who were incapable 
of giving consent for TLE (due to brain damage, 
whAt’s nEw?
Our study evaluated indications for transvenous lead extraction (TLE), its 
effectiveness, safety, and 30 ‑day follow ‑up in patients at the age of 80 years 
or younger and those older than 80 years. Compared with younger patients, 
the octogenarians had more comorbidities and more frequently underwent 
TLE due to infection. The TLE procedure is effective, and its outcomes are 
similar to those obtained in patients at a younger age. The adverse event 
and procedural success rates were similar for octogenarians and younger 
patients. The key difference was the increased all ‑cause mortality in octo‑
genarians within the 30 ‑day follow ‑up after TLE, which was linked to higher 
morbidity. In this subgroup of patients, potential benefits of complex TLE for 
indications other than infection should be carefully weighed against the high 
risk of unfavorable short ‑term outcome.
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(67 patients [10%]), LI (62 patients [9.3%]), and 
for indications other than infection (538 pa‑
tients [80.7%]). Both LDIE and LI coexisted in 
21 patients (3.1%). There were 90 octogenar‑
ians (13.5%) at a mean (SD) age of 83.8 (2.8) 
years (range, 80.4–93 years), and 577 younger 
patients at a mean (SD) age of 64.2 (12.5) years 
(range, 18.9–79.9 years).
The clinical characteristics of both groups are 
shown in tAbLE 1. The female sex was more preva‑
lent in octogenarians compared with the young‑
er group (44.4% vs 34.7%; P = 0.07). Octogenar‑
ians had higher mean values of LVEF and creati‑
nine as well as a lower NYHA class. They also had 
significantly lower BMI, hemoglobin levels, and 
eGFR (tAbLE 1). Both groups differed with regard 
to the type of implanted devices. The percentage 
of patients with pacemakers was higher in octoge‑
narians, whereas the percentage of those on cardi‑
ac resynchronization therapy and with ICDs was 
higher in the younger group (P <0.001) (tAbLE 1).
Octogenarians twice more often had a device‑
‑related infection (LDIE and / or LI) than young‑
er patients (33.3% vs 17.1%; P <0.001) (tAbLE 1). 
The groups did not differ in terms of the preva‑
lence of diabetes, coronary artery disease, and 
the number of previously performed device‑
‑related procedures (tAbLE 1). Overall morbidity 
measured with the CCI was higher in octogenar‑
ians than in younger patients (2.4 vs 2; P = 0.02).
The total number of extracted leads in both 
groups was 1032 (138 leads in octogenarians and 
894 leads in the younger group). The comparison 
of extracted leads and results of TLE in both study 
groups are shown in tAbLE 2. The percentage of ex‑
tracted ICD leads was higher in younger patients 
than in octogenarians (21.7% vs 11.6%; P = 0.006).
The groups had a similar percentage of uni‑
polar pacing leads, passive fixation leads, aban‑
doned leads, and patients with 3 or more extract‑
ed leads, as well as a similar number of extracted 
leads at the index procedure (tAbLE 2). Additional‑
ly, the mean age of extracted leads, age of extract‑
ed pacing and ICD leads, oldest extracted leads, 
and the total age of all extracted leads were com‑
parable between the groups (tAbLE 2).
Complete lead removal rates were similar 
in octogenarians and younger patients (98.6% 
and 97.1%, respectively; P = 0.48). We did not 
observe any differences between the groups in 
the use of extraction tools (P = 0.43). The time 
of a single permanent pacemaker (PPM) or ICD 
lead extraction was longer in younger patients 
compared with octogenarians; however, the dif‑
ference did not reach significance (P = 0.08). 
The fluoroscopy time of PPM or ICD lead extrac‑
tion and the fluoroscopy time of ICD lead ex‑
traction were longer in the younger group com‑
pared with octogenarians (tAbLE 2). The fluoros‑
copy time of PPM lead extraction was compara‑
ble between groups (tAbLE 2).
The effectiveness of procedures in the whole 
population was high and similar in both groups 
(P  = 0.7). Complete procedural success was 
of both) when the residual part neither increases 
the risk of perforation, embolic events, or nonre‑
solving infection nor causes any undesired out‑
come; and 3) failure of the procedure—inability 
to achieve either complete procedural or clinical 
success, developing any permanently disabling 
adverse event, or procedure ‑related death.1-3 For 
each removed lead, the efficacy (complete or in‑
complete) was determined according to the EHRA 
consensus.3 A complete lead removal was defined 
as lead explantation or extraction with removal 
of all targeted lead material, whereas an incom‑
plete lead removal referred to lead explantation 
or extraction where a part of the lead remained 
in the patient’s body (in the vascular or extravas‑
cular space).3 We recorded adverse events that oc‑
curred during the intraoperative period and with‑
in 30 days after the procedure and classified them 
into 2 types in accordance with the Heart Rhythm 
Society and EHRA consensus.1-3
transvenous lead extraction The  description 
of TLE was presented elsewhere.13 Pacemaker‑
‑dependent patients who underwent TLE due 
to infection were bridged to reimplantation 
with a temporary active fixation lead implant‑
ed on the ipsilateral side of the chest and con‑
nected to an external permanent pacemaker 
generator.14 Furthermore, in patients at a very 
high risk of sudden cardiac death, we implanted 
a temporary external ICD as a bridge to the ICD 
reimplantation.15
statistical analysis The  analysis was per‑
formed using the Statistica software, version 
13.1 (StatSoft, Tulsa, Oklahoma, United States). 
Continuous variables were expressed as mean 
(SD) or median and interquartile range (IQR). 
The Shapiro–Wilk test was used to assess nor‑
mality of data distribution. Two groups of con‑
tinuous variables were compared with the t test 
of unpaired samples, and in the case of data dis‑
tribution other than normal or a small sample 
size, the Mann–Whitney test was applied. Cat‑
egorical variables were presented as the number 
and percentage of observations in each catego‑
ry. Those data were compared with the χ2 test, 
χ2 test with the Yates continuity correction, or 
Fisher exact test, as appropriate. Univariable and 
multivariable logistic regression was performed 
to determine the independent predictors of 30‑
‑day mortality. Odds ratios (ORs) with 95% CIs 
were used to present the impact of independent 
variables on 30 ‑day mortality. Predictors with 
a P value of less than 0.1 in the univariable anal‑
ysis were selected for the multivariable logis‑
tic regression analysis. All statistical tests were 
2 ‑tailed and a P value of less than 0.05 was con‑
sidered significant.
rEsuLts We identified 667 patients at a mean 
(SD) age of 66.9 (13.4) years (range, 18.9–93 
years), including 240 women (36%). Transve‑
nous lead extraction was performed due to LDIE 
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Four deceased patients had indications for TLE 
other than infection. Three patients in the young‑
er group died of the following causes: 1 patient 
during TLE, 1 of heart failure after cardiac sur‑
gery, and 1 of thromboembolic events. One octo‑
genarian died of thromboembolic events.
The association between selected factors and 
30 ‑day all ‑cause mortality following TLE is pre‑
sented in tAbLE 3. Factors entered into the univari‑
able analysis of the 30 ‑day mortality included: 
the octogenarian vs younger group status, sex, 
LVEF, BMI, LDIE as an indication for TLE, hemo‑
globin levels, CCI, number of extracted leads at the 
index procedure, total age of all extracted leads, 
presence of a dual ‑coil ICD lead extracted, total 
fluoroscopy time during all lead extractions, and 
presence of major adverse events of TLE.
The univariable analysis showed that the oc‑
togenarian status (OR, 3.027), lower LVEF (OR, 
1.035 per 1%), LDIE as an indication for TLE 
(OR, 23.375), lower hemoglobin levels (OR, 
2.024 per 1 g/dl), higher CCI (OR, 2.274 per 1 
point), and the number of extracted leads at the 
index procedure (OR, 4.583 per 1 lead) were 
achieved in 642 patients (96.3%); clinical suc‑
cess, in 15 (2.2%); and failure, in 10 (1.5%). In 
octogenarians, complete success was achieved in 
88 patients (97.8%), while in the younger group, 
in 554 patients (96%) of patients.
In the  entire study group, there were 11 
(1.5%) minor and 9 (1.3%) major complications. 
The safety of TLE was similar in both groups (P 
= 0.45). In octogenarians, 2 minor and no ma‑
jor complications were reported. In the younger 
group, minor and major complications occurred 
in the equal percentage of patients, namely, 1.6% 
(9 patients).
All ‑cause mortality within 30 days after TLE 
was 2.4% (16 patients) and a significant differ‑
ence was found between groups (5.6% in octoge‑
narians vs 1.9% in the younger group; P = 0.04) 
(tAbLE 2). Among patients who died, 11 had LDIE 
(3 octogenarians and 8 younger patients; all died 
of severe heart failure or sepsis while being on 
antibiotic therapy). One patient died due to ad‑
verse events after a fall that resulted in hemor‑
rhage to the pleural cavity (in octogenarians, af‑
ter TLE due to LI).
tAbLE 1 Clinical characteristics of patients as well as the type of implanted devices and leads in the study groups
Variable All patients  
(n = 667)
Octogenarians 
(n = 90)
Younger patients 
(n = 577)
P value
Age, y 66.9 (13.4); 68.3; 17.6 83.8 (2.8); 83.3; 4.2 64.2 (12.5); 66.2; 16.4 –
Female sex, n (%) 240 (36) 40 (44.4) 200 (34.7) 0.07
LVEF, % 43.6 (16.1); 45; 28 48.9 (12.8); 50; 20 42.8 (16.5); 45; 28 0.001
NYHA class III or IV, n (%) 169 (25.3) 15 (16.7) 154 (26.7) 0.04
BMI, kg/m2 27.9 (4.8); 27.5; 6.1 26.4 (3.6); 26.4; 4.6 28.1 (4.9); 27.7; 6.2 0.001
Hemoglobin, g/dl 13.6 (1.7); 13.8; 2.2 13.1 (1.8); 13.4; 2.6 13.7 (1.7); 13.9; 2.2 0.004
Creatinine, µmol/l 100.9 (53.8); 91; 35 105.7 (32.6); 98.5; 35 100.2 (56.4); 89; 32 0.001
eGFR, ml/min/1.73 m2 68.1 (22.2); 69; 32 54.5 (16.6); 52.1; 25 70.3 (22.2); 71; 32 <0.001
Diabetes mellitus, n (%) 221 (33.1) 34 (37.8) 187 (32.4) 0.31
Coronary artery disease, n (%) 367 (55) 57 (63.3) 310 (53.7) 0.09
Charlson Comorbidity Index 2.1 (1.7); 2; 2 2.4 (1.6); 2; 3 2 (1.7); 2; 2 0.02
Previous TLE procedures, n 1.6 (0.9); 1; 1 1.6 (0.8); 1; 1 1.7 (0.9); 1; 1 >0.99
Implanted 
device, n (%)
Pacemaker 408 (61.2)a 73 (81.1) 335 (58.1)a <0.001
ICD 177 (26.5)b 12 (13.3) 165 (28.6)b
CRT ‑P 11 (1.7) 0 11 (1.9)
CRT ‑D 71 (10.6)c 5 (5.6) 66 (11.4)c
Indications for 
TLE, n (%)
LDIE 67 (10) 12 (13.3) 55 (9.5) <0.001
LI 62 (9.3) 18 (20) 44 (7.6)
Other than 
infection
538 (80.7) 60 (66.7) 478 (82.9)
Data are presented as mean (SD) and median; IQR unless otherwise indicated.
a In 2 patients: in 1 patient—no pacing system, remaining 2 leads after the removal of a dual ‑chamber pacemaker 
due to a device ‑pocket infection; in 1 patient—no pacing system, a remaining VDD lead after pacemaker removal due 
to an indication other than infection
b In 1 patient: no pacing system, a remaining ICD lead after unsuccessful lead removal in another center
c In 1 patient: no pacing system, a remaining fragment of an ICD lead after heart transplant
Abbreviations: BMI, body mass index; CRT ‑D, cardiac resynchronization therapy defibrillator; CRT ‑P, cardiac 
resynchronization therapy pacemaker; eGFR, estimated glomerular filtration rate; ICD, implantable cardioverter‑
‑defibrillator; IQR, interquartile range; LDIE, lead ‑dependent infective endocarditis; LI, local infection; LVEF, left 
ventricular ejection fraction; NYHA, New York Heart Association; TLE, transvenous lead extraction
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dIscussIon The current state of knowledge 
regarding safety, effectiveness, and particular‑
ly survival after TLE in elderly patients is still 
limited. In our study cohort, indications for TLE 
other than infection were present in 80.7% of 
patients. The observed low rate of TLE due to in‑
fection results from our strategy to rigorously 
treat pacing ‑related adverse events and is con‑
sistent with our previous report.16 The decision 
whether or not to perform TLE was based on 
significant predictors of 30 ‑day mortality. In the 
multivariable analysis, only lower hemoglobin lev‑
els (OR, 1.642 per 1 g/dl), higher CCI (OR, 1.836 
per 1 point), and the number of extracted leads 
at the index procedure (OR, 3.441 per 1 lead) re‑
mained significant. The results of the statistical 
analysis are presented in tAbLE 3. Octogenarians 
and younger patients with LDIE as an indication 
for TLE had similar 30 ‑day all ‑cause mortality 
(60% and 72.7%, respectively; P = 0.94).
tAbLE 2 Extracted leads and results of transvenous lead extraction in both study groups
Variable All patients 
(n = 667)
Octogenarians 
(n = 90)
Younger patients 
(n = 577)
P value
Extracted leads, total n 1032 138 894 –
Extracted ICD leads, n (%) 210 (20.3) 16 (11.6) 194 (21.7) 0.006
Unipolar pacing leads, n (%) 70 (8.5) 5 (4.1) 65 (9.3) 0.07
Passive fixation leadsa, n (%) 315 (30.5) 34 (24.6) 281 (31.4) 0.11
Age of an extracted lead, y 7.5 (5.8); 6; 6.2 7.2 (5.2); 6.6; 5.1 7.6 (5.9); 6; 6.3 0.47
Age of an extracted pacing lead, y 8 (6.1); 6.5; 6.8 7.5 (5.3); 6.9; 5.2 8.1 (6.3); 6.4; 7.2 0.26
Age of an extracted ICD lead, y 5.5 (3.4); 5; 4.3 4.6 (2.3); 4.6; 3.5 5.6 (3.5); 5.1; 4.4 0.45
Oldest extracted lead, y 7.9 (6.2); 6.1; 6.4 7.5 (5.5); 6.6; 5.2 8 (6.3); 6; 6.7 0.94
Total age of extracted leads, y 11.6 (10.2); 8.3; 10.9 11 (9.3); 7.6; 10.3 11.7 (10.4); 8.4; 11 0.34
Patients with 1 abandoned lead, n (%) 26 (3.9) 5 (5.6) 21 (3.6) 0.56
Patients with 2 abandoned leads, n (%) 4 (0.6) 1 (1.1) 3 (0.5) 0.44
Patients with 3 or more extracted leads, n (%) 37 (5.5) 3 (3.3) 34 (5.9) 0.46
Extracted leads at the index procedure, n 1.5 (0.6); 1; 1 1.5 (0.6); 1.5; 1 1.5 (0.6); 1; 1 0.98
Lead removal, n (%)
Complete lead removal 1004 (97.3) 136 (98.6) 868 (97.1) 0.48
Incomplete lead removal 28 (2.7) 2 (1.4) 26 (2.9)
Techniques finally used
Simple traction, n (%) 233 (22.6) 38 (27.5) 195 (21.8) 0.43
Telescopic sheaths, n (%) 754 (73.1) 93 (67.4) 661 (74)
Evolution mechanical system, n (%) 22 (2.1) 3 (2.2) 19 (2.1)
Femoral access, n (%) 23 (2.2) 4 (2.9) 19 (2.1)
Fluoroscopy time during single pacing or ICD lead removala, min 2.1 (3.6); 1.1; 1.8 1.8 (2.8); 1; 1.5 2.2 (3.7); 1.1; 1.8 0.08
Fluoroscopy time during single pacing lead removala, min 2 (3.4); 1; 1.8 1.9 (2.9); 1; 1.6 2.1 (3.5); 1; 1.8 0.36
Fluoroscopy time during single ICD lead removal, min 2.4 (4.1); 1.3; 1.7 1.2 (1.2); 1; 1.6 2.5 (4.3); 1.3; 1.9 0.049
Total fluoroscopy time during all lead removal procedures, min 3.3 (5.2); 1.7; 2.7 2.8 (5); 1.1; 2.5 3.4 (5.2); 1.8; 2.8 0.02
Procedure outcome, n (%)
Complete success 642 (96.3) 88 (97.8) 554 (96) 0.7
Clinical success 15 (2.2) 1 (1.1) 14 (2.4)
Failure 10 (1.5) 1 (1.1) 9 (1.6)
Complications, n (%)
None 648 (97.2) 88 (97.8) 559 (96.8) 0.45
Minor 11 (1.5) 2 (2.2) 9 (1.6)
Major 9 (1.3) 0 9 (1.6)
Deaths, n (%)
In the intraoperative period, procedure ‑related 1 (0.15) 0 1 (0.2) >0.99
Postoperatively within 30 days after TLE, procedure ‑related 0 0 0 >0.99
Postoperatively within 30 days after TLE, non–procedure ‑related 16 (2.4) 5 (5.6) 11 (1.9) 0.04
Data are presented as mean (SD) and median; IQR unless otherwise indicated.
a Including left ventricular leads
Abbreviations: see tAbLE 1
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number of ICD leads were extracted in young‑
er patients.6 Our data are in line with the stud‑
ies by Kutarski et al6 and Williams et al8 with re‑
gard to a similar age of extracted leads in both 
groups. On the other hand, the literature provides 
conflicting results with a shorter lead dwell time 
in elderly patients compared with younger ones 
(29 months vs 42 months; P = 0.03) shown by Pel‑
argonio et al5 as opposed to a longer lead dwell 
time (59.6 months vs 38.6 months; P = 0.04) re‑
ported by Rodrigez et al.7
The total fluoroscopy time during extraction 
of all leads was longer in younger patients than 
in octogenarians. In our opinion, it was related 
to longer fluoroscopy time during ICD lead ex‑
traction in the younger group compared with oc‑
togenarians (2.5 min vs 1.2 min; P = 0.049) and 
a higher prevalence of ICD leads in the younger 
group (21.7% vs 11.6%; P = 0.006). As reported 
in the literature, removing ICD leads, particularly 
the dual ‑coil ones, increases fluoroscopy time and 
requires more advanced equipment.13 The fluoros‑
copy time only during the PPM lead extraction 
was similar in both groups. As shown in our pre‑
vious study, the older age of leads is also a major 
predictor of long fluoroscopy during TLE,17 where‑
as in the current study, we observed a similar age 
of extracted leads in both groups. No reports con‑
cerning fluoroscopy time in a population divid‑
ed by age can be found in the available literature.
As observed in the previous trials, both young‑
er and older patients required similar lead extrac‑
tion techniques.5,7,8
The complete procedural success rates were 
97.8% in octogenarians and 96% in younger pa‑
tients, which is in line with the findings of other 
authors: Pelargonio et al5 reported 97% and 96%, 
respectively (P = 0.39), and Kutarski et al,6 97.4% 
and 94.6%, respectively (P = 0.14). Lower rates 
of complete procedural success were reported by 
a careful consideration of the pros and cons of 
lead abandonment and extraction, in line with 
patient preferences.17 This process was in line 
with the current expert consensus statement.2 
The tendency toward a higher frequency of 
noninfectious indications for TLE was previous‑
ly noted in other Polish centers.18,19 Our results, 
like the previous publication from Poland,6 show 
that patients over 80 years were referred for TLE 
due to infection more frequently than young‑
er patients, who underwent TLE predominant‑
ly due to noninfectious causes. On the contrary, 
Rodriguez et al7 reported that the number of in‑
fectious indications for TLE was similarly distrib‑
uted in young and elderly patients.7 As suggest‑
ed by Kennergren et al,10 it may indicate that el‑
derly patients are less likely to be offered TLE due 
to noninfectious indications and may be treated 
conservatively.10 
Regarding the prevalence of LI in our study, 
this type of device ‑related infection dominat‑
ed among octogenarians, whereas other inves‑
tigators observed no significant difference be‑
tween both groups.5,6 In our study, a higher prev‑
alence of women in octogenarians compared with 
the younger group did not reach significance, pre‑
sumably due to a low number of octogenarians. It 
has been reported previously that women prevail 
in the elderly population.5-7 As expected, the lon‑
ger life expectancy in women compared with men 
is a likely explanation. In line with other studies, 
octogenarians were in better cardiovascular con‑
dition reflected by the NYHA class and LVEF as 
well as had fewer ICDs implanted than young‑
er patients.5,7 
Octogenarians in our study had significantly 
lower hemoglobin levels and higher morbidity as‑
sessed by the CCI, which is in agreement with pre‑
vious reports.5,7,8 Similarly to the data published 
by other Polish authors, a significantly higher 
tAbLE 3 Predictors of all ‑cause mortality within 30 days after transvenous lead extraction
Variable Univariable analysis Multivariable analysis
OR 95% CI P value OR 95% CI P value
Octogenarians vs younger patients 3.027 1.026–8.926 0.045 3.058 0.758–12.339 0.12
Female sex 1.069 0.384–2.979 0.9 – – –
LVEF, 1% decrease 1.035 1.002–1.068 0.04 1 0.950–1.053 0.99
BMI, 1‑kg/m2 decrease 1.071 0.955–1.2 0.24 – – –
LDIE as an indication for TLE 23.375 7.843–69.668 <0.001 3.307 0.843–12.966 0.09
Hemoglobin, 1‑g/dl decrease 2.024 1.572–2.604 <0.001 1.642 1.178–2.278 0.003
CCI, 1 ‑point increase 2.274 1.614–3.203 <0.001 1.836 1.193–2.827 0.006
Number of extracted leads at 
the index procedure, 1 ‑lead increase
4.583 2.171–9.672 <0.001 3.441 1.330–8.903 0.01
Total age of extracted leads, 
1 ‑year increase
0.989 0.938–1.044 0.7 _ _ _
Dual ‑coil ICD lead extraction 3.035 0.835–11.034 0.09 1.979 0.308–12.73 0.47
Total fluoroscopy time during all lead 
extractions, 1 ‑minute increase
0.92 0.77–1.1 0.36 – – –
Major complications of TLE 5.358 0.63–45.588 0.12 – – –
Abbreviations: CCI, Charlson Comorbidity Index; OR, odds ratio; others, see tAbLE 1
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(8632 high ‑voltage and 2942 pacing lead extrac‑
tions), performed in 762 centers, the authors re‑
ported a mortality rate of 0.12% during TLE,20 
which is comparable with our findings.
Similarly to the reports of other authors, all‑
‑cause mortality within 30 days after TLE was 
2.4% in our study. Gould et al21 reported a 30‑
‑day all ‑cause mortality rate of 2.3% in 925 pa‑
tients, Williams et al,8 a rate of 2.5% (10 patients 
in 406 procedures), and Brunner et al22 showed 
an even lower rate of 2.2%. Of note, the latter 
analysis included patients with a mean lead dwell 
time of 4.7 years, whereas in our study the lead 
dwell time was markedly longer and amount‑
ed to 6.5 years. On the other hand, Deckx et al23 
showed higher mortality (3.4%) within 1 month 
after the procedure.
We noted that octogenarians had higher 30‑
‑day all ‑cause mortality than the younger group. 
One in 20 octogenarians did not survive 1 month 
after TLE due to various causes. In the univari‑
able analysis, the risk factors for all ‑cause 30‑
‑day mortality, apart from the octogenarian sta‑
tus, were reduced LVEF, LDIE as an indication 
for TLE, low hemoglobin levels, higher CCI, and 
the number of extracted leads at the index proce‑
dure. In the multivariable analysis, the indepen‑
dent risk factors for increased 30 ‑day all ‑cause 
mortality were low hemoglobin levels, higher CCI, 
and the number of extracted leads at the index 
procedure. Williams et al9 did not demonstrate 
higher 30 ‑day all ‑cause mortality in elderly pa‑
tients; however, all cases of death occurred in 
patients undergoing extraction of infected de‑
vices and were attributable to overwhelming 
sepsis.9 Previous studies also showed that sep‑
sis (systemic infection) accounted for the ma‑
jority of deaths within 30 days after TLE.21-23 
In our study, the multivariable analysis showed 
only a trend toward a higher 30 ‑day mortali‑
ty rate in patients with LDIE in octogenarians. 
The stronger association of LDIE with mortality 
in this group in the univariable as compared with 
multivariable analysis (OR, 23.375; P <0.001 vs 
OR = 3.307; P = 0.09) showed the modifying ef‑
fect of multimorbidity.
Gould et al21 and Brunner et al22 demonstrat‑
ed that the age of patients at the index TLE pro‑
cedure was associated with a higher risk of peri‑
procedural death in the univariable analysis. In‑
terestingly, the ELECTRa registry analysis showed 
that the age above 68 years was one of the predic‑
tors of increased all ‑cause mortality during hos‑
pitalization (OR, 2.42; P = 0.008).9
In agreement with our results, in the study 
by Brunner et al,22 reduced LVEF in the univari‑
able analysis was a predictor of periprocedur‑
al death; however, in the multivariable analy‑
sis, it tended to be related to higher mortali‑
ty (OR, 1.7; P = 0.148). Anemia proved to be in‑
dependently associated with increased mortal‑
ity, which corresponds with previous reports. 
Brunner et al22 showed a 3 ‑fold increase of mor‑
tality in patients with low hemoglobin levels. 
Williams et al8: 91.7% in elderly patients vs 91.3% 
in younger ones. Bongiorni et al9 noted complete 
clinical and radiological success rates in 96.7% 
of older patients and 95.7% of younger ones. 
The findings from the ELECTRa registry and 
the study by Bongiorni et al9 are in agreement 
with our results. Importantly, the ELECTRa reg‑
istry has not been analyzed in terms of complete 
clinical and radiological success in a population 
divided by age.
The percentage of major and minor complica‑
tions was similar in octogenarians and younger 
patients, amounting to 1.3% and 1.5%, respective‑
ly (P = 0.45). Pelargonio et al5 reported the rates 
of 1.1% for major (2% in elderly patients and 0.9% 
in younger ones) and 3.1% for minor complica‑
tions (4% in elderly patients and 2.9% in young‑
er ones). Kutarski et al6 observed major compli‑
cations in 1.56% of elderly patients and 1.51% 
of younger ones (P = 0.79), and minor compli‑
cations, in 1% of elderly patients and 1.88% of 
younger ones (P = 0.6). Furthermore, Rodriguez 
et al7 demonstrated no significant difference in 
the rate of minor (P = 0.65) and major (P = 0.56) 
complications between elderly and younger pa‑
tients. On the contrary, Williams et al8 report‑
ed a higher rate of complications in elderly pa‑
tients compared with younger ones (P = 0.01). 
In the multivariate logistic regression analysis, 
they showed that the octogenarian status was as‑
sociated with a 6.45 ‑fold higher OR of complica‑
tions (major and minor). In the prospective mul‑
ticenter ELECTRa registry, the procedure ‑related 
major and minor complication rates were 1.7% 
and 5%, respectively. In general, the complica‑
tion rates are comparable to our results in terms 
of major complications and markedly higher for 
minor complications.9 Importantly, the subanal‑
ysis of the ELECTRa registry with regard to pa‑
tients’ age has not been conducted so far.
We reported 1 case of procedure ‑related death 
in the entire study population (0.15%), which 
occurred in a woman from the younger group 
(0.2%). No procedure ‑related deaths were record‑
ed in octogenarians. Similar results were shown 
by Rodrigez et al,7 with 1 death in the nonocto‑
genarian group. A slightly larger number of peri‑
procedural deaths was noted by Pelargonio et al5; 
however, the mortality rate was comparable be‑
tween younger and older patients (0.7% vs 1.3%; 
P = 0.45). No intraprocedural deaths occurred 
in the groups of younger and elderly patients in 
the study by Williams et al.8 Moreover, Kutarski 
et al6 reported 4 cases of death (0.31%) in the peri‑
procedural period in 1252 patients undergoing 
TLE.6 Additionally, the procedure ‑related mor‑
tality in our study is in line with another large 
prospective analysis on TLE. In the ELECTRa 
registry, there were 17 procedure ‑related deaths 
(0.5%; 1% in low ‑volume centers and 0.4% in 
high ‑volume centers).9 Brunner et al11 reported 
a total of 11 procedure ‑related deaths (0.4%), in‑
cluding 6 intra‑ and 5 postoperative ones. In a re‑
cently published registry of 11 304 TLE procedures 
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study limitations We acknowledge that our study 
has several important limitations. First, we ana‑
lyzed a relatively small sample of octogenarians 
and conducted the study in a single center. Sec‑
ond, no comparison was made between mechan‑
ical systems (dilator sheaths and the Evolution 
system) and other techniques currently used for 
TLE, as we used mechanical systems only. Third, 
the follow ‑up was limited to a 30 ‑day postpro‑
cedural period.
conclusions In conclusion, the octogenarians in 
our study, compared with younger patients, had 
more comorbidities and underwent TLE more fre‑
quently due to infection. We showed that TLE is 
effective and safe, and the outcomes are similar 
to those obtained in patients at a younger age.
The adverse event and procedural success rates 
were similar for octogenarians and younger pa‑
tients. We observed a higher 30 ‑day all ‑cause 
mortality within 30 days after TLE in octogenar‑
ians, which was associated with higher morbidi‑
ty and lower hemoglobin levels. In this subgroup 
of patients, the potential benefits of the proce‑
dure should be considered against the high risk 
of unfavorable short ‑term outcomes following 
complex TLE for indications other than infection.
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